ARCHIVES

Will Latest Report By Rosenberg Stir Up Critics? Some DCT Board Members Defend the Press

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002

Feinstein Slams Cancer Act Proposal, Calls White Paper Vague And Unrealistic.

October 19, 2001

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

Stem Cell Transplant More Effective than Chemotherapy

April 25, 2003

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Centers Program Needs ‘Innovative Additions’ Such as SPORE Grants

September 20, 1991